Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (361-370 of 669) with videos related to

Pageof 67
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 25, 2018
Modulating ROS to overcome multidrug resistance in cancerQingbin Cui, Jing-Quan Wang, Yehuda G Assaraf, et al.
Journal of Medicinal Chemistry|April 30, 2014
Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acidSatyakam Singh, Nagarajan Rajendra Prasad, Eduardo E Chufan, et al.
Bioorganic & Medicinal Chemistry|August 29, 2018
Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR)Liming Chang, Mengwu Xiao, Linlin Yang, et al.
Bioorganic Chemistry|March 26, 2023
Design, synthesis, and biological evaluation of phenylurea indole derivatives as ABCG2 inhibitorsGao-Jie Ye, Chao-Yun Cai, Xing-Duo Dong, et al.
Journal of Medicinal Chemistry|October 19, 2024
Cell-Based Screen Identifies a Highly Potent and Orally Available ABCB1 Modulator for Treatment of Multidrug ResistanceShuai Wang, Sai-Qi Wang, Xiao-Bing Chen, et al.
Molecular Medicine Reports|September 14, 2017
GOLPH3 promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma via mTOR and Wnt/β‑catenin signal activationJian-Hua Wang, Lin-Jing Yuan, Rong-Xin Liang, et al.
Frontiers in Oncology|February 15, 2021
Target Inhibition of CBP Induced Cell Senescence in BCR-ABL- T315I Mutant Chronic Myeloid LeukemiaKe Yang, Fang Wang, Hong Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 25, 2025
Functional tumor-reactive CD8 + T cells in pancreatic cancerHongwei Sun, Changying Shi, Guoqing Fang, et al.
Signal Transduction and Targeted Therapy|March 22, 2023
Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repairXin Peng, Yingying Wang, Shaolu Zhang, et al.
Frontiers in Pharmacology|March 30, 2022
The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 TransporterHan Fu, Zhuo-Xun Wu, Zi-Ning Lei, et al.
Pageof 67

Showing results (361-370 of 669) with videos related to

Sort By:
Pageof 67
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 25, 2018
Modulating ROS to overcome multidrug resistance in cancerQingbin Cui, Jing-Quan Wang, Yehuda G Assaraf, et al.
Journal of Medicinal Chemistry|April 30, 2014
Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acidSatyakam Singh, Nagarajan Rajendra Prasad, Eduardo E Chufan, et al.
Bioorganic & Medicinal Chemistry|August 29, 2018
Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR)Liming Chang, Mengwu Xiao, Linlin Yang, et al.
Bioorganic Chemistry|March 26, 2023
Design, synthesis, and biological evaluation of phenylurea indole derivatives as ABCG2 inhibitorsGao-Jie Ye, Chao-Yun Cai, Xing-Duo Dong, et al.
Journal of Medicinal Chemistry|October 19, 2024
Cell-Based Screen Identifies a Highly Potent and Orally Available ABCB1 Modulator for Treatment of Multidrug ResistanceShuai Wang, Sai-Qi Wang, Xiao-Bing Chen, et al.
Molecular Medicine Reports|September 14, 2017
GOLPH3 promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma via mTOR and Wnt/β‑catenin signal activationJian-Hua Wang, Lin-Jing Yuan, Rong-Xin Liang, et al.
Frontiers in Oncology|February 15, 2021
Target Inhibition of CBP Induced Cell Senescence in BCR-ABL- T315I Mutant Chronic Myeloid LeukemiaKe Yang, Fang Wang, Hong Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 25, 2025
Functional tumor-reactive CD8 + T cells in pancreatic cancerHongwei Sun, Changying Shi, Guoqing Fang, et al.
Signal Transduction and Targeted Therapy|March 22, 2023
Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repairXin Peng, Yingying Wang, Shaolu Zhang, et al.
Frontiers in Pharmacology|March 30, 2022
The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 TransporterHan Fu, Zhuo-Xun Wu, Zi-Ning Lei, et al.
Pageof 67